Sees FY23 estimated reported sales $96.9B-$97.9B, consensus $97.84B.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on JNJ:
- Johnson & Johnson Reports Earnings: Did it Beat Estimate Forecasts?
- JNJ Gains after Better-than-Expected Q4 Results
- Pharma Industry Could Benefit from Rise in Medicine Spending
- Johnson & Johnson (NYSE:JNJ) Q4 Earnings Preview: Here’s What to Expect
- Johnson & Johnson put buyer realizes 33% same-day gains